Shucai Yang Selected Research

Carcinogens

8/2019	Ambient fine particulate matter inhibits 15-lipoxygenases to promote lung carcinogenesis.
1/2019	EGFR-AS1/HIF2A regulates the expression of FOXP3 to impact the cancer stemness of smoking-related non-small cell lung cancer.
1/2016	Tumorigenesis of smoking carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is related to its ability to stimulate thromboxane synthase and enhance stemness of non-small cell lung cancer stem cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shucai Yang Research Topics

Disease

17	Neoplasms (Cancer) 01/2021 - 10/2008
4	Lung Neoplasms (Lung Cancer) 08/2019 - 10/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 10/2011
4	Lymphatic Metastasis 05/2014 - 10/2008
3	Neoplasm Metastasis (Metastasis) 01/2017 - 11/2010
2	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 01/2020
2	Hypoxia (Hypoxemia) 01/2020 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2018
2	Carcinogenesis 08/2019 - 01/2016
2	Carcinoma (Carcinomatosis) 05/2014 - 04/2009
1	Papillary Thyroid Cancer 01/2021
1	Bites and Stings (Sting) 03/2019
1	Hypertrophy 01/2019
1	Osteoporosis 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Atherosclerosis 01/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2012
1	Transitional Cell Carcinoma 11/2010
1	Ovarian Epithelial Carcinoma 04/2009
1	Disease Progression 04/2009
1	Melanoma (Melanoma, Malignant) 10/2008
1	Cutaneous Malignant Melanoma 10/2008

Drug/Important Bio-Agent (IBA)

4	Vascular Endothelial Growth Factor DIBA 05/2014 - 10/2008
3	CarcinogensIBA 08/2019 - 01/2016
3	Vascular Endothelial Growth Factor CIBA 05/2014 - 10/2008
2	Estrogen Receptor alphaIBA 01/2022 - 01/2021
2	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2019
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2019
2	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 01/2019 - 01/2016
2	CateninsIBA 01/2019 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2010 - 04/2009
1	Estrogen ReceptorsIBA 01/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022
1	PPAR gammaIBA 01/2021
1	LigandsIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Particulate MatterIBA 08/2019
1	Phosphotransferases (Kinase)IBA 03/2019
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 03/2019
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 03/2019
1	InterferonsIBA 03/2019
1	CalciumIBA 01/2019
1	SphingosineIBA 01/2019
1	KetonesIBA 01/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	CholesterolIBA 01/2019
1	Nicotine FDA Link 01/2019
1	NitrosaminesIBA 01/2019
1	PlatinumIBA 01/2019
1	Antisense RNA (Anti-Sense RNA)IBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	ozagrelIBA 01/2016
1	ThromboxanesIBA 01/2016
1	Small Interfering RNA (siRNA)IBA 05/2014
1	ras ProteinsIBA 05/2014
1	CD100 antigenIBA 05/2014
1	arctigeninIBA 08/2012
1	Mitogen-Activated Protein KinasesIBA 08/2012
1	Chemokine ReceptorsIBA 10/2011
1	Biological ProductsIBA 10/2011
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2011
1	AntibodiesIBA 11/2010
1	Indicators and Reagents (Reagents)IBA 04/2009
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 10/2008
1	Vascular Endothelial Growth FactorsIBA 10/2008
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2008

Therapy/Procedure

3	Therapeutics 03/2019 - 05/2014
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2020
1	Chemoprevention 08/2012
1	Aftercare (After-Treatment) 08/2012